中国药房2024,Vol.35Issue(7) :783-786.DOI:10.6039/j.issn.1001-0408.2024.07.03

《药品标准管理办法》解读与思考

Interpretation and reflection on the Measures for the Administration of Standards for Medicinal Products

赵梦遐 孙丽娜 徐丹 柴文 江学孔 毛志海 贺盛亮
中国药房2024,Vol.35Issue(7) :783-786.DOI:10.6039/j.issn.1001-0408.2024.07.03

《药品标准管理办法》解读与思考

Interpretation and reflection on the Measures for the Administration of Standards for Medicinal Products

赵梦遐 1孙丽娜 2徐丹 3柴文 4江学孔 4毛志海 5贺盛亮3
扫码查看

作者信息

  • 1. 湖北科技学院医学部公共卫生与健康学院,湖北 咸宁 437100
  • 2. 湖北省药品监督管理局审评中心,武汉 430071
  • 3. 咸宁市咸安区公共检验检测中心,湖北 咸宁 437000
  • 4. 湖北省药品监督管理局咸宁分局,湖北 咸宁 437100
  • 5. 真奥金银花药业有限公司,湖北咸宁 437000
  • 折叠

摘要

2023年7月,国家药品监督管理局发布《药品标准管理办法》(以下简称《办法》).本文就《办法》的主要内容进行解读,分析其存在的不足为:《办法》现有条文中对药品标准代号和药品标准信息化建设目标未明确.建议国家药品监督管理部门及时向标准化主管部门申请药品标准代号"YB"字母的确权,并将药品标准代号、编号规则在下一轮《办法》修正时写入条文,同时明确药品标准信息化体系建设目标;按用户界面层、计算处理层、数据存储层的基本框架搭建国家药品标准数据共享平台,免费向社会公开数字化药品标准,提供查阅和下载服务.

Abstract

In July 2023,the National Medical Products Administration issued the Measures for the Administration of Standards for Medicinal Products(hereinafter referred to as the Measures).This article interprets the main content of the Measures,and analyzes its shortcomings as unclear definition of the drug standard code and the goals of drug standard information construction.It is recommended that the national drug regulatory department promptly apply to the standardization authority for the confirmation of the drug standard code"YB"letter,and the drug standard code and numbering rules would be included in the next round of amendments to the Measures.It is necessary to clarify the construction goals of the information system for drug standards at the same time,and build a national drug standard data-sharing platform based on the basic framework of user interface layer,computing processing layer,and data storage layer.Digital drug standards will be free,and access and download services for the public will be provided.

关键词

药品标准管理办法/药品标准代号/药品注册标准/信息化/解读

Key words

Measures for the Administration of Standards for Medicinal Products/drug standard code/drug registration standards/informatization/interpret

引用本文复制引用

基金项目

湖北省药品监督管理局科研面上项目(20220132)

出版年

2024
中国药房
中国医院协会,中国药房杂志社

中国药房

CSTPCD北大核心
影响因子:0.956
ISSN:1001-0408
参考文献量14
段落导航相关论文